Effect of inpatient palliative care on quality of life 2weeks after hematopoietic stem cell transplantation: A randomized clinical trial

JAMA - Journal of the American Medical Association

Volumn 316, Issue 20, 2016, Pages 2094-2103

  El Jawahri, Areej ^a,b   Le Blanc, Thomas ^c   Van Dusen, Harry ^a,b   Traeger, Lara ^a,b   Greer, Joseph A ^a,b   Pirl, William F ^a,b   Jackson, Vicki A ^a,b   Telles, Jason ^a,b   Rhodes, Alison ^a,b   Spitzer, Thomas R ^a,b   McAfee, Steven ^a,b   Chen, Yi Bin A ^a,b   Lee, Stephanie S ^d   Temel, Jennifer S ^a,b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d USA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE LYMPHOBLASTIC LEUKEMIA; ACUTE MYELOID LEUKEMIA; ADULT; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; CANCER CHEMOTHERAPY; CANCER PALLIATIVE THERAPY; CAREGIVER; CHARLSON COMORBIDITY INDEX; CHRONIC MYELOID LEUKEMIA; CLINICAL EFFECTIVENESS; CONSTIPATION; CONTROLLED STUDY; DEPRESSION; DIARRHEA; EDUCATION; FATIGUE; FEMALE; FUNCTIONAL ASSESSMENT; HEMATOLOGIC MALIGNANCY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HOSPITAL ANXIETY AND DEPRESSION SCALE; HOSPITAL PATIENT; HUMAN; INCOME; INSOMNIA; LENGTH OF STAY; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; MOOD; MULTIPLE MYELOMA; MYELODYSPLASTIC SYNDROME; MYELOFIBROSIS; NAUSEA; PAIN; POSTTRAUMATIC STRESS DISORDER; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; REDUCED INTENSITY CONDITIONING; SYMPTOM; SYMPTOMATOLOGY; UNRELATED DONORS; ADVERSE EFFECTS; AGED; ANXIETY; HEMATOLOGIC NEOPLASMS; HOSPITALIZATION; MIDDLE AGED; PALLIATIVE THERAPY; PATIENT COMFORT; PROCEDURES; TREATMENT OUTCOME;

ADULT; AGED; ANXIETY; CAREGIVERS; DEPRESSION; FATIGUE; FEMALE; HEMATOLOGIC NEOPLASMS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HOSPITALIZATION; HUMANS; INPATIENTS; MALE; MIDDLE AGED; PALLIATIVE CARE; PATIENT COMFORT; QUALITY OF LIFE; TREATMENT OUTCOME;

EID: 85006086199     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2016.16786     Document Type: Article

References (29)

1. Pidala J, Anasetti C, Jim H. Health-related quality of life following haematopoietic cell transplantation: patient education, evaluation and intervention. Br J Haematol. 2010;148(3):373-385.
2. Pidala J, Anasetti C, Jim H. Quality of life after allogeneic hematopoietic cell transplantation. Blood. 2009;114(1):7-19.
3. McQuellon RP, Russell GB, Rambo TD, et al. Quality of life and psychological distress of bone marrow transplant recipients: The "time trajectory" to recovery over the first year. Bone Marrow Transplant. 1998;21(5):477-486.
4. El-Jawahri AR, Traeger LN, Kuzmuk K, et al. Quality of life and mood of patients and family caregivers during hospitalization for hematopoietic stem cell transplantation. Cancer. 2015;121(6):951-959.
5. Prieto JM, Atala J, Blanch J, et al. Patient-rated emotional and physical functioning among hematologic cancer patients during hospitalization for stem-cell transplantation. Bone Marrow Transplant. 2005;35(3):307-314.
6. Fife BL, Huster GA, Cornetta KG, Kennedy VN, Akard LP, Broun ER. Longitudinal study of adaptation to the stress of bone marrow transplantation. J Clin Oncol. 2000;18(7):1539-1549.
7. El-Jawahri AR, Vandusen HB, Traeger LN, et al. Quality of life and mood predict posttraumatic stress disorder after hematopoietic stem cell transplantation. Cancer. 2016;122(5):806-812.
8. DeFor TE, Burns LJ, Gold EM,Weisdorf DJ. A randomized trial of the effect of a walking regimen on the functional status of 100 adult allogeneic donor hematopoietic cell transplant patients. Biol Blood Marrow Transplant. 2007;13(8): 948-955.
9. Syrjala KL, Donaldson GW, DavisMW, Kippes ME, Carr JE. Relaxation and imagery and cognitive-behavioral training reduce pain during cancer treatment: A controlled clinical trial. Pain. 1995;63(2):189-198.
10. Syrjala KL, Cummings C, Donaldson GW. Hypnosis or cognitive behavioral training for the reduction of pain and nausea during cancer treatment: A controlled clinical trial. Pain. 1992;48 (2):137-146.
11. Lee SJ, Joffe S, Kim HT, et al. Physicians' attitudes about quality-of-life issues in hematopoietic stem cell transplantation. Blood. 2004;104(7):2194-2200.
12. Howell DA, Shellens R, Roman E, Garry AC, Patmore R, Howard MR. Haematological malignancy: are patients appropriately referred for specialist palliative and hospice care? a systematic review and meta-analysis of published data. Palliat Med. 2011;25(6):630-641.
13. Manitta VJ, Philip JA, Cole-Sinclair MF. Palliative care and the hemato-oncological patient: can we live together? a review of the literature. J Palliat Med. 2010;13(8):1021-1025.
14. Epstein AS, Goldberg GR, Meier DE. Palliative care and hematologic oncology: The promise of collaboration. Blood Rev. 2012;26(6):233-239.
15. McQuellon RP, Russell GB, Cella DF, et al. Quality of life measurement in bone marrow transplantation: development of the Functional Assessment of Cancer Therapy-Bone Marrow Transplant (FACT-BMT) scale. Bone Marrow Transplant. 1997;19(4):357-368.
16. Santana MJ, Au HJ, Dharma-Wardene M, et al. Health-related quality of life measures in routine clinical care: can FACT-Fatigue help to assess the management of fatigue in cancer patients? Int J Technol Assess Health Care. 2009;25(1):90-96.
17. Zigmond AS, Snaith RP. The Hospital Anxiety and Depression Scale. Acta Psychiatr Scand. 1983; 67(6):361-370.
18. Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001;16(9):606-613.
19. Watanabe SM, Nekolaichuk CL, Beaumont C. The Edmonton Symptom Assessment System, a proposed tool for distress screening in cancer patients: development and refinement. Psychooncology. 2012;21(9):977-985.
20. Sorror ML, Maris MB, Storb R, et al. Hematopoietic cell transplantation (HCT)-specific comorbidity index: A new tool for risk assessment before allogeneic HCT. Blood. 2005;106(8):2912-2919.
21. Minaya P, Baumstarck K, Berbis J, et al. The CareGiver Oncology Quality of Life questionnaire (CarGOQoL): development and validation of an instrument to measure the quality of life of the caregivers of patients with cancer. Eur J Cancer. 2012;48(6):904-911.
22. Temel JS, Greer JA, Muzikansky A, et al. Early palliative care for patients with metastatic non-small-cell lung cancer. N Engl J Med. 2010;363 (8):733-742.
23. Bakitas M, Lyons KD, Hegel MT, et al. Effects of a palliative care intervention on clinical outcomes in patients with advanced cancer: The Project ENABLE II randomized controlled trial. JAMA. 2009;302(7):741-749.
24. Zimmermann C, Riechelmann R, Krzyzanowska M, Rodin G, Tannock I. Effectiveness of specialized palliative care: A systematic review. JAMA. 2008; 299(14):1698-1709.
25. Zimmermann C, Swami N, KrzyzanowskaM, et al. Early palliative care for patients with advanced cancer: A cluster-randomised controlled trial. Lancet. 2014;383(9930):1721-1730.
26. Bakitas MA, Tosteson TD, Li Z, et al. Early vs delayed initiation of concurrent palliative oncology care: patient outcomes in the ENABLE III randomized controlled trial. J Clin Oncol. 2015;33 (13):1438-1445.
27. LeBlanc TW, El-Jawahri A. When and why should patients with hematologic malignancies see a palliative care specialist? Hematology Am Soc Hematol Educ Program. 2015;2015(1):471-478.
28. Syrjala KL, Chapko MK, Vitaliano PP, Cummings C, Sullivan KM. Recovery after allogeneic marrow transplantation: prospective study of predictors of long-term physical and psychosocial functioning. Bone Marrow Transplant. 1993;11(4):319-327.
29. Fraser CJ, Bhatia S, Ness K, et al. Impact of chronic graft-vs-host disease on the health status of hematopoietic cell transplantation survivors: A report from the Bone Marrow Transplant Survivor Study. Blood. 2006;108(8):2867-2873.